Hesperetin as an adjuvant augments protective anti‐tumour immunity responses in B16F10 melanoma by stimulating cytotoxic CD8⁺ T cells

Abstract

Hesperetin (HES) is a dihydroflavone with the molecular formula of C16H14O6. It has been reported that Hesperetin has antioxidant and anticancer effects. Recent studies showed that it can also regulate immune responses. To assess its potential function as a vaccine adjuvant, we formulated HES with inactivated B16F10 melanoma cells and determined whether it would enhance the activation of antigen‐presenting cells by experiments in vivo and in vitro. We found that HES activated the PI3K‐Akt signalling pathway in antigen‐presenting cells (APCs), enhanced cytotoxic T lymphocyte (CTL) responses and deactivated tolerogenic T cells. We also observed that inactivated B16F10 cells in combination with HES vaccine inhibited the growth of mice tumours, resulting in improved overall survival compared to the effects of inactivated B16F10 cell vaccine. To verify that CD8+T cells play a key role in inhibiting the development of melanoma, we transferred the sorted CD8+T cells from immunized mice to B16F10 challenged models and found that the survival rate of tumour‐bearing mice was significantly prolonged. Taken together, these results suggest that hesperetin can be used as a potential adjuvant to improve tumour immune responses and antigen immunogenicity.

Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits

“…Hesperidin has multiple antimicrobial, antioxidant, anti-tumor, antihypertensive and immunostimulant medicinal properties [14,57,[88][89][90][91][92][93][94][95][96][97]. Therefore, citrus fruits could have positive effects in the course of COVID-19 with additional mechanisms, besides the inhibition of virus replication and antioxidant activity.…”

Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review

“…The researchers found that HSP suppressed the level of polyamine, spermidine, spermine and upregulated the activity of transglutaminase (TGase), thereby inhibiting cell growth and metastasis [111]. Furthermore, a recent study on the same cell line and female C57BL/6 mice demonstrated that HSP at 125 mg/mL doses could inhibit melanogenic tumour growth by activating PI3K-Akt signalling and cytotoxic T lymphocyte and suppressed the tolerogenic T cell response [112]. HSP induced apoptosis in both in vitro (Eca-109) and in vivo (female BALB/C nude mice) on oesophagal Eca-109 cancer cells at 0-500 μM/30-90 mg/kg concentration.…”

Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives

“…It has been shown that hesperetin (25 µM) activated host cellular and humoral responses [105], enhanced LPS-mediated in vitro proliferation of splenocytes, and potentiated killing activity of NK and CTLs [105]. Moreover, hesperetin activated antigen presenting cells (APCs), enhanced CTL response, and antitumor immunity when used as an adjuvant at 2.65 µmol/mouse in combination with inactivated B16F10 melanoma cells vaccine which prolonged the survival of tumor-bearing mice [106].…”